Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Sales | 816 | 1,380 | 897 | 1,255 | 2,089 |
| Gross Profit | 800 | 880 | 890 | 780 | 160 |
| Operating Expenses | 6,660 | 5,850 | 6,210 | 5,900 | 8,910 |
| Operating Income | -5,844 | -4,470 | -5,313 | -4,645 | -6,821 |
| Interest Expense | -3 | 7 | 7 | 9 | 0 |
| Other Income | 281 | -253 | 300 | -66 | 1,061 |
| Pre-tax Income | -5,560 | -4,730 | -5,020 | -4,720 | -5,760 |
| Income Tax | -216 | 10 | 6 | 20 | -200 |
| Net Income Continuous | -5,437 | -4,698 | -5,042 | -7,573 | -5,486 |
| Net Income | $-5,437 | $-4,698 | $-5,042 | $-7,573 | $-5,486 |
| EPS Basic Total Ops | -4.32 | -3.24 | -4.32 | -6.12 | -3.96 |
| EPS Basic Continuous Ops | -3.69 | -3.20 | -3.45 | -5.19 | -3.83 |
| EPS Diluted Total Ops | -4.32 | -3.24 | -4.32 | -6.12 | -3.96 |
| EPS Diluted Continuous Ops | -3.69 | -3.20 | -3.45 | -5.19 | -3.83 |
| EBITDA(a) | $-5,134 | $-4,490 | $-5,303 | $-4,495 | $-6,211 |